the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Aug 5, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a special monitoring system can help identify and manage agitation in critically ill patients in the Intensive Care Unit (ICU). The aim is to see if this multi-modal evaluation, which uses remote video technology to detect signs of agitation, is effective over a period of three years. Agitation can be distressing for patients and caregivers, so understanding how to monitor and address it is very important.
To be eligible for the study, patients need to be between 18 and 65 years old and at risk of becoming agitated in the ICU. They must also have a specific score that indicates they are at risk for this behavior. However, some people cannot participate, such as those with certain medical conditions or those who do not have the ability to provide consent. If chosen to participate, patients can expect to have their agitation monitored as part of their regular care, which may help improve their overall treatment experience in the ICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients at risk of agitation in the ICU
- • Patients with RASS score -2 and above
- • ≦ 65 years old, ≧ 18 years old
- Exclusion Criteria:
- • The affected party refused to participate in this study
- • Missing/incomplete information
- • Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives
- • Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression
- • Patients with limb impairment and amputation
- • Spinal cord injury, limb movement/sensory limitations
- • Patients with pre-existing neurological/psychiatric diseases
- • Patients with malignant tumors
- • Patients with infectious diseases
- • Patients with terminal disease and dying disease
- • Abnormal behavior due to head injury or craniocerebral disease
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Hanzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported